Compound Screening TRIZ Cases

Single-cell sequencing identifies activated odorant receptors directly from native olfactory neurons.

Compounds modulate specific gene expression to inhibit alpha-synuclein mediated cellular toxicity in neuronal cells.

Peptides targeting specific galectin-7 residues block dimer formation, resolving the trade-off between inhibitor efficacy and molecular weight.

An Atlastin 2 inhibitor composition reduces endoplasmic reticulum and mitochondria binding to address cellular dysfunction.

Soluble ActRII polypeptides bypass erythropoietin resistance to raise red blood cell levels without compromising bone density.

GCC2-exosome marker composition detects lung cancer via specific primer or antibody binding.

AR condensate modulators target the intrinsic disorder domain to decrease transcriptional complex levels.

PMVK inhibiting siRNA reduces protein levels to enhance radiation sensitivity, overcoming resistance without damaging normal tissues.

A sol-gel protein chip immobilizes target proteins to enable rapid screening of inhibitors against specific molecular interactions.

Multi-omics platform identifies drug mechanisms of action through integrated transcriptomics, proteomics, and metabolomics analysis.

Triple knockout pro-B cells express autonomously active B-cell receptors to select antibodies that bind tumor epitopes while sparing healthy cells.

Segmented heteromeric and homomeric T1R receptor assays distinguish physiologically relevant interactions to improve prediction accuracy.

Aptamer-functionalized capacitive biosensors detect microorganisms via real-time capacitance changes.

A screening assay identifies MYCBP2 modulators using hydroxy-containing substrates to measure ligase activity.

A protease-activated reporter system detects protein-protein interactions in cell-based assays.

Riboflavin-mediated photo-oxidation breaks down lipofuscin deposits that resist cellular clearance in retinal diseases.

LGI3 expression measurement resolves the contradiction between early detection capability and severity determination accuracy.

Gel microdrop composition encapsulates antibody-producing cells and distinct reporter particles to enable precise bioactive compound identification.

Methods screen chimeric molecules using temporary ribotoxicity reduction to identify cytotoxic proteins with improved binding affinity.

Phospho-specific antibodies detect human ATR kinase phosphorylated at serine 428.

A hepatocyte culture system evaluates drug metabolism effects using supernatant from xenobiotic-stimulated immune cells.

Macrocyclic peptides replace complex antibodies by blocking PD-L1 interactions, reducing therapy costs while enhancing immune response against tumors.

Autophagy-inhibiting peptides block p38 MAPK signaling to reduce vascular permeability and prevent edema during fluid resuscitation.

In situ synthesized peptide-MHC assemblies on spatially ordered arrays enable direct detection of immunodominant peptides.

Deep learning models synthesize fluorescent signals from bright-field images, eliminating invasive marker introduction while maintaining measurement precision.

Trimerized polypeptides sequester surface CRPs to sensitize tumor cells to antibody-mediated complement-dependent cytolysis.

Heterologous stimulus-gated ion channels resolve poor selectivity in cell activation by enabling precise control through light, heat, or ligand triggers.

Compounds disrupt the protective MUC1-chaperone complex to sensitize cancer cells to chemotherapy agents.

Inhibiting LRG expression resolves the gap between diagnostic markers and therapeutic targets, improving treatment efficacy for inflammatory diseases.

Pre-immunized animals neutralize active agents to eliminate false negatives and reduce testing time.

A protein-degradation inducing tag binds proteases to trigger ubiquitin-independent target protein breakdown.

A 3D lung cancer cell model establishes vascular tubes between culture substrates for drug screening.

Small molecules block the Nef-calnexin protein interaction to restore cholesterol efflux, reversing HIV-induced atherosclerosis risk.

A set of fluorescently labeled intracellular lipid binding proteins measures fluorescence indices at two wavelengths to calculate unbound free fatty acid concentrations.

Measuring SHROOM3 gene expression enables early detection of fibrosis progression, allowing timely therapeutic intervention to prevent end-stage renal disease.

Induced leukemia stem cell-like cells enable high-throughput identification of therapeutic targets and modulators.

Structural parameter changes create FGFR-selective pharmacophores that reduce adverse side effects from VEGFR2 and PDGFR-beta inhibition.

Segmenting phagocytic cells by DNA content eliminates reliance on population averages, enabling accurate personalized disease detection.

Segmented Transwell setup with LPS induction resolves complexity in studying nanoliposome absorption mechanisms.

Pre-stressed bandages shield wounds from endogenous and exogenous stress to prevent hypertrophic scarring.

Magnetic bead enrichment concentrates pathogens from blood samples for rapid antibiotic susceptibility testing within hours.

Gamma loop peptides stabilize thrombin at room temperature, eliminating refrigeration needs and protease inhibitor requirements for clinical use.

Reconstructed skin models replicate infant barrier properties to evaluate formulation efficacy against urine exposure.

Oral serotonin receptor 5-HT2A inhibitor resolves treatment complexity and cost trade-offs in dystonia management.

Varying xNA length tunes SERCA inhibition strength, resolving the trade-off between binding reliability and therapeutic adaptability.